CHRISTINA BOMAN: Open Payments
NPI 1932743572 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,101 in 79 payments from 31 companies in 2025. Trend: 2023 $748 · 2024 $859 · 2025 $2,101
Food & beverage: $1,943Education: $158
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $399 |
| Gilead Sciences, Inc. | 7 | $183 |
| Daiichi Sankyo Inc. | 6 | $149 |
| Novartis Pharmaceuticals Corporation | 5 | $139 |
| Regeneron Healthcare Solutions, Inc. | 6 | $129 |
| Merck Sharp & Dohme LLC | 4 | $119 |
| AstraZeneca Pharmaceuticals LP | 4 | $101 |
| Lilly USA, LLC | 2 | $99 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Genentech USA, Inc. | 3 | $62 |
Products named: Trodelvy, RYBREVANT, KEYTRUDA, LIBTAYO, Vanflyta, DARZALEX, CARVYKTI, JAYPIRCA.
Industry payments across TX — which companies pay providers there.
